Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED

NANot yet recruitingINTERVENTIONAL
Enrollment

4,704

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

July 31, 2028

Conditions
Non-Alcoholic Fatty Liver DiseaseSteatosis of Liver
Interventions
BEHAVIORAL

STIRRED

"The STIRRED intervention is a behavioral intervention directed at the treating ED clinicians.~An Our Practice Advisory (OPA) will alert the clinician to the radiology finding of hepatic steatosis at the time of preparing the discharge materials. The OPA will prompt the clinician to discuss this finding with the patient and will automatically add hepatic steatosis to the discharge diagnoses and insert patient-facing discharge information about hepatic steatosis. It will additionally prompt the clinician to refer the patient for follow-up which will be stratified based on their fibrosis risk level."

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

collaborator

University of Texas, Southwestern Medical Center at Dallas

OTHER

lead

Northwestern University

OTHER

NCT06944353 - Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED | Biotech Hunter | Biotech Hunter